ReNerve showcased its novel tissue-based products at the Royal Australasian College of Surgeons’ Annual Scientific Congress, held in Melbourne in May. The conference, which had both face-to-face and virtual attendees, is the largest multi-disciplinary meeting held in Australia and New Zealand, providing a valuable opportunity to raise the company’s profile.
During the conference ReNerve met with numerous surgeons, generating a high level of interest in the company’s products, the NervAlign® Nerve Cuff and NervAlign® Nerve Graft. The ReNerve team discussed the company’s research and development program, which focuses on the development of tissue-based products to transform the repair and regeneration of damaged nerves and related soft tissue repairs. Visitors to the booth were able to examine a prototype of the Nerve Cuff, and feedback indicated significant interest in using the product in the clinic.
ReNerve’s approach uses science and clinical insights to develop cleaner, safer, better tissue-based products for improved patient recovery and long-term outcomes. Developed in Melbourne in collaboration with CSIRO, Monash University and industry partners, the technology aims to provide a superior environment for nerve repair and regeneration. A marketing approval application for its first product, the NervAlign® Nerve Cuff, is currently being reviewed by the FDA